<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Palczewska G</submitter><funding>National Eye Institute</funding><funding>NEI NIH HHS</funding><funding>the European Union’s Horizon 2020 research and innovation programme</funding><funding>the National Institutes of Health (NIH)</funding><funding>NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>121555</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6171813</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>3(17)</volume><pubmed_abstract>Noninvasive imaging of visual system components in vivo is critical for understanding the causal mechanisms of retinal diseases and for developing therapies for their treatment. However, ultraviolet light needed to excite endogenous fluorophores that participate in metabolic processes of the retina is highly attenuated by the anterior segment of the human eye. In contrast, 2-photon excitation fluorescence imaging with pulsed infrared light overcomes this obstacle. Reducing retinal exposure to laser radiation remains a major barrier in advancing this technology to studies in humans. To increase fluorescence intensity and reduce the requisite laser power, we modulated ultrashort laser pulses with high-order dispersion compensation and applied sensorless adaptive optics and custom image recov</pubmed_abstract><journal>JCI insight</journal><pubmed_title>Two-photon imaging of the mammalian retina with ultrafast pulsing laser.</pubmed_title><pmcid>PMC6171813</pmcid><funding_grant_id>T32 GM007250</funding_grant_id><funding_grant_id>EY R24024864</funding_grant_id><funding_grant_id>R24 EY027283</funding_grant_id><funding_grant_id>P30 EY011373</funding_grant_id><funding_grant_id>P30 EY025585</funding_grant_id><funding_grant_id>S10 OD016164</funding_grant_id><funding_grant_id>T32 EY024236</funding_grant_id><funding_grant_id>F30 EY029136</funding_grant_id><funding_grant_id>U01 EY025451</funding_grant_id><funding_grant_id>R24 EY024864</funding_grant_id><funding_grant_id>grant No. 666295</funding_grant_id><funding_grant_id>EY027283,U01 EY025451</funding_grant_id><pubmed_authors>Suh S</pubmed_authors><pubmed_authors>Salom D</pubmed_authors><pubmed_authors>Ruminski D</pubmed_authors><pubmed_authors>Choi EH</pubmed_authors><pubmed_authors>Wojtkowski M</pubmed_authors><pubmed_authors>Palczewski K</pubmed_authors><pubmed_authors>Stremplewski P</pubmed_authors><pubmed_authors>Palczewska G</pubmed_authors><pubmed_authors>Dong Z</pubmed_authors><pubmed_authors>Alexander N</pubmed_authors><pubmed_authors>Sears AE</pubmed_authors><pubmed_authors>Kern TS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Two-photon imaging of the mammalian retina with ultrafast pulsing laser.</name><description>Noninvasive imaging of visual system components in vivo is critical for understanding the causal mechanisms of retinal diseases and for developing therapies for their treatment. However, ultraviolet light needed to excite endogenous fluorophores that participate in metabolic processes of the retina is highly attenuated by the anterior segment of the human eye. In contrast, 2-photon excitation fluorescence imaging with pulsed infrared light overcomes this obstacle. Reducing retinal exposure to laser radiation remains a major barrier in advancing this technology to studies in humans. To increase fluorescence intensity and reduce the requisite laser power, we modulated ultrashort laser pulses with high-order dispersion compensation and applied sensorless adaptive optics and custom image recov</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Sep</publication><modification>2026-06-14T05:42:34.701Z</modification><creation>2019-03-27T00:01:20Z</creation></dates><accession>S-EPMC6171813</accession><cross_references><pubmed>30185665</pubmed><doi>10.1172/jci.insight.121555</doi></cross_references></HashMap>